Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era

Postgraduate Medical Journal

Volumn 79, Issue 938, 2003, Pages 691-694

  Allen, S H ^a   Brennan Benson, P ^a   Nelson, M ^a   Asboe, D ^a   Bower, M ^a   Azadian, B ^a   Gazzard, B ^a   Stebbing, J ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT;

AIDS RELATED COMPLEX; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; COHORT ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LOBAR PNEUMONIA; LYMPHOCYTE COUNT; MALE; PNEUMONIA; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HIV-1; HUMANS; MALE; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; VIRAL LOAD;

EID: 1642578296     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Paul S, Gilbert HM, Lande L, et al. Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Res Hum Retroviruses 2002;18:501-6.
2. Sullivan JH, Moore RD, Keruly JC, et al. Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection. Am J Respir Crit Care Med 2000;162:64-7.
3. Wolff AJ, O'Donnell AE. Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy. Chest 2001;120:1888-93.
4. Mayaud C, Parrot A, Cadranel J. Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients. Eur Respir J Suppl 2002;36:28s-39.
5. Janoff EN, Breiman RF, Daley CL, et al. Pneumococcal disease during HIV infection: epidemiological, clinical, and immunological perspectives. Ann Intern Med 1992;117:314-24.
6. Jordens JZ, Paul J, Bates J, et al. Characterisation of Streptococcus pneumoniae from human immunodeficiency virus-seropositive patients with acute and recurrent pneumonia. J Infect Dis 1995;172:983-7.
7. McEllistrem MC, Mendelsohn AB, Pass MA, et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 2002;185:1364-8.
8. Dworkin MS, Ward JW, Hanson DL, et al. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001;32:794-800.
9. File TM Jr. Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae. Clin Infect Dis 2002;34(suppl 1):S17-26.
10. Reacher M, Shah A, Livermore DM, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-6.
11. Taylor IK, Coker RJ, Clarke J, et al. Pulmonary complications of HIV disease: 10 year retrospective evaluation of yields from bronchoalveolar lavage, 1983-98. Thorax 1995;50:1240-5.
12. Salisbury DM, Begg NT, eds. Department of Health, Welsh Office, Scottish Office Department of Health, DHSS (Northern Ireland). Immunization against infectious disease. London: HMSO, 1996:168.
13. Jain A, Jain S, Gant V. Should patients positive for HIV infection receive pneumococcal vaccine? BMJ 1995;310:1060-2.
14. Jefferson T, Demicheli V. Polysaccharide pneumococcal vaccines. BMJ 2002;325:292-3.
15. Manfredi R, Nanetti A, Ferri M, et al. Pseudomonas spp complications in patients with HIV disease: an eight year clinical and microbiological survey. Eur J Epidemiol 2000;16:111-18.
16. Sorvillo F, Beall G, Turner PA, et al. Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. Am J Infect Control 2001;29:79-84.
17. Carmelli Y, Troillet N, Karchmer AW, et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999;159:1127-32.